One-Third of Cancer Patients Have a Genetic Profile Accessible by Their Oncologist

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 24, 2016 – A new market research report titled Personalized Medicine’s Effect on Oncologists’ Treatment Regimens, from Industry Standard Research (ISR), finds that, according to US-based oncologists, currently one-quarter of patients are treated using genetic tumor profiling to inform treatment decisions and … Continued

Two-thirds of Biopharma Sponsors Surveyed Currently Sell or Plan to Sell Biosimilar Products

Informing the pharmaceutical drug development, manufacturing and commercialization industry. Cary, NC – May 17, 2016 – A new report titled Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd edition), from Industry Standard Research (ISR), indicates that the majority of companies with a large molecule offering plan to enter or are already involved in the … Continued

Use Peers’ Experiences To Make Educated CRO Selections

Director of Market Research at Industry Standard Research Rebecca McAvoy discusses with Life Science Leader about how you can use data from other decision-makers to have confidence in your own outsourcing decisions. Having access to performance data from CROs’ users is crucial in making an informed CRO selection. However, it is a lot of information … Continued

ISR CUSTOMERS